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Complications and Patient-reported
Outcomes after TRAM and DIEP Flaps:
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Introduction: Transverse rectus abdominis myocutaneous (TRAM) and deep inferior
epigastric artery perforator (DIEP) flaps are the most common abdominally based
breast reconstruction procedures. Each technique has its advantages and disadvantages; however, how morbidity relates to satisfaction is not well-understood. Our aim
was to compare complications and patient-reported outcomes following pedicled
TRAM (pTRAM), free TRAM (fTRAM), and DIEP flaps to guide flap selection.
Methods: A systematic literature search was conducted, and 2 independent reviewers identified comparative studies of abdominally based flaps. Data were extracted
on patient characteristics, complications, and patient-reported outcomes. Metaanalyses were conducted using random effects modeling with the DerSimonian
and Laird method.
Results: The search retrieved 5090 articles, of which 18 were included in this
review. pTRAM flaps trended toward a higher risk of abdominal bulge/hernia
compared with DIEP flaps, particularly in low-volume hospitals. While fTRAM
flaps had a higher risk of abdominal morbidity compared with DIEP flaps, relative
risk decreased when obese patients were excluded and when only muscle-sparing
fTRAM flaps were compared. Muscle-sparing flaps had a higher risk of flap loss
than fTRAM flaps. Compared with DIEP flaps, pTRAM flaps were associated with
lower general satisfaction but comparable emotional well-being.
Conclusions: Our findings indicate that safety and satisfaction following abdominally based breast reconstruction depend on flap type and patient characteristics.
When possible, DIEP or muscle-sparing fTRAM flaps should be performed for obese
patients to decrease the risk of abdominal bulge/hernia. Although pTRAM flaps
are associated with a greater risk of flap loss, they are still an appropriate option
when microsurgery is not available. (Plast Reconstr Surg Glob Open 2020;8:e3120; doi:
10.1097/GOX.0000000000003120; Published online 29 October 2020.)

INTRODUCTION

Although implant-based reconstruction is the most
common approach to breast reconstruction,1,2 autologous
reconstruction is also well established and is associated
with increased patient satisfaction and quality of life.3 Of
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women who elect to undergo breast reconstruction following mastectomy, 13 percent had autologous reconstruction using abdominally based tissue.13 This includes
pedicled transverse rectus abdominis (pTRAM), free
TRAM (fTRAM), and deep inferior epigastric (DIEP) flap
reconstructions. With greater public concern surrounding
implant-based reconstruction and recent FDA initiatives
to explore breast implant safety,2,3 we anticipate a rise in
autologous reconstruction in the near future. Thus, there
exists a need to re-examine flap selection criteria based on
contemporary literature.
Disclosure: The authors have no financial interest to declare
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unrestricted research funding from Vioptix and is co-founder
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Related Digital Media are available in the full-text
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Previous studies show that DIEP and muscle-sparing
(MS) fTRAM flaps have a decreased incidence of abdominal bulge/hernia compared with pTRAM and non-muscle-sparing fTRAM flaps, suggesting that harvesting less
muscle results in better donor-site outcomes.4,5 DIEP flaps,
while sparing abdominal rectus muscle, are associated
with a higher rate of flap loss and fat necrosis, presumably
from a less robust blood flow compared with the fTRAM
flap and technical challenges of perforator dissection.6–8
Despite these differences in complication rates, little is
known regarding how postoperative morbidity correlates
with patient-reported outcomes. While some surveys show
no difference in patient satisfaction following DIEP and
non-muscle-sparing fTRAM flaps,9–12 there is less literature
comparing DIEP flaps to MS fTRAM or pTRAM flaps.
Additionally, because most flap selection criteria rely
on intraoperative indications or conventional recommendations based on patient characteristics, the relationship
between preoperative risk factors and complications for
abdominally based flap reconstruction remains unclear.
In particular, while obesity and lower hospital procedural
volume status have been shown to lead to overall higher
risk of postoperative morbidity,13–19 impact on safety outcomes has not yet been summarized according to abdominally based flap type.
To our knowledge to date, a systematic review and
meta-analysis comparing complications and quality of life
for all major abdominally based breast reconstruction
techniques, and assessing the impact of preoperative risk
factors, have not yet been performed.4–6,16 An improved
understanding of these outcomes is critical so that patients
and providers can have informed discussions about expectations for recovery during the shared decision-making
process. The aim of this study was to compare safety and
patient-reported outcomes following pedicled (pTRAM),
free TRAM (fTRAM), and DIEP flaps, as well as to assess
whether these differ on the basis of obesity and hospital
procedural volume status, to guide optimal flap selection.

METHODS
Study Selection and Data Extraction

MEDLINE, EMBASE, the Cochrane Central Register
of Controlled Trials, Web of Science, and Scopus were
systematically queried for studies of breast reconstruction following mastectomy for cancer, according to our
systematic review protocol (PROSPERO registration
CRD42020147475). Covidence (Melbourne, Australia)
was used to manage study selection, quality assessment,
and data extraction. Study selection was based on predefined eligibility criteria in a Population, Intervention,
Comparison, Outcome, Timing, and Setting (PICOTS)
framework (See appendix, Supplemental Digital Content 1,
which displays a PICOTS (population, interventions, comparators, outcomes, timing, and setting) for the key questions. Appendix B. Risk of bias across included studies of
complications and patient-reported outcomes. http://
links.lww.com/PRSGO/B491). Following PRISMA guidelines, 2 reviewers independently screened abstracts and
full text articles to identify comparative studies of pedicled,
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free, and muscle-sparing free TRAM and DIEP flap breast
reconstructions published after 2000. References of
included studies were searched for additional relevant
titles.
Two reviewers independently assessed the risk of
bias for individual studies using the Risk of Bias in NonRandomised Studies of Interventions (ROBINS-I),20 and
extracted data on general study characteristics, patient
characteristics, and complications and patient-reported
outcomes. Differences between reviewers at any stage were
resolved through consensus.
Statistical Analysis

To standardize results, we conducted the meta-analyses
for complications to reflect the authors’ definitions from
each study. Hospital procedural volume was calculated
as the number of abdominally-based autologous breast
reconstructions performed per year during the study
period, and institutions in the lower 50th percentile were
classified as low-volume.
Meta-analyses for outcomes were conducted using a
random effects model with the DerSimonian and Laird
method when there were at least 2 sufficiently homogeneous studies. Associations between flap type (ie, pTRAM,
fTRAM, and DIEP flaps) and complications were reported
as effect sizes with 95% confidence intervals. A post-hoc
sensitivity analysis was conducted using the HartungKnapp-Sidik-Jonkman method. Subgroup analyses were
conducted using flap subtypes (ie, MS fTRAM flaps)
as well as patient- and hospital-level factors. A HaldaneAnscombe correction was used for outcomes with small
counts. All meta-analyses were conducted using Microsoft
Excel (version 16).

RESULTS

The search retrieved 5090 unique articles, of which
4132 were excluded during abstract screening and 940
were excluded during full-text screening (Fig. 1). A total
of 18 articles were ultimately included in this systematic
review.9–14,21–32 Overall risk of bias was low for 5 and moderate for 11 studies (see Supplemental Digital Content
1, http://links.lww.com/PRSGO/B491). Fifteen articles assessed safety,9–11,13,14,21–30,32 and 8 provided patientreported outcomes (Table 1).9–12,14,25,31,32 All were cohort
studies, with the exception of 1 cross-sectional study.31
Complications

Pooled estimates demonstrated a trend toward higher
abdominal bulge/hernia rates (RR = 2.82, 95% CI = 0.83–
4.80) following pTRAM compared to DIEP flaps, which
increased in a subgroup analysis with only low-volume hospitals (RR = 3.08, 95% CI = 0.46–5.70) (Table 2). Similarly,
there were trends toward higher relative risks of flap loss,
mastectomy skin flap necrosis, fat necrosis, and wound
healing complications following pTRAM compared with
DIEP flaps in low-volume hospitals, although these did not
reach statistical significance.
Patients undergoing fTRAM were 2.87 times more
likely to experience abdominal bulge/hernia (95%
CI = 1.73–4.00) than patients undergoing DIEP flap
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Fig. 1. Summary of the study selection process, showing the included 18 unique articles.

reconstruction (Table 3). However, relative risk decreased
to 2.35 when obese patients were excluded in a subgroup analysis (95% CI = 1.49–3.21) and 2.55 when only
MS fTRAM flaps were compared to DIEP flaps (95%
CI = 1.42–3.67) (Fig. 2). DIEP flaps were associated with
a greater risk of flap loss (ES = 2.67, 95% CI = 1.00–4.34)
than fTRAM, although relative risk decreased (RR = 1.93,
95% CI = 0.26–3.61) in a comparison of DIEP with only
MS fTRAM flaps. Differences in mastectomy skin flap
necrosis, fat necrosis, infection, hematoma/seroma, and
wound healing complications after fTRAM and DIEP flap
reconstructions did not reach statistical significance.
Only one study reported on the development of hypertrophic scarring and keloids. It was found that breast scars
developed after 2.3% of DIEP flap reconstructions, while
none developed after pedicled or free TRAM flap reconstructions.10 A comparable, low rate of abdominal donorsite scarring was seen after DIEP (1.4%), pedicled TRAM
(1.3%), and free TRAM (1.1%) flap reconstructions.
Patient-reported Outcomes

Four articles reported on psychosocial outcomes;9,10,14,25
4 on satisfaction outcomes;9,10,31,32 5 on physical well-being
outcomes;9–12,14 and 1 on pain (Table 4).11 Studies used the
BREAST-Q9,10 and Short Form-36 (SF-36)14,25 to measure
psychosocial outcomes. In the Mastectomy Reconstruction
Outcomes Consortium study, BREAST-Q psychosocial and
sexual well-being scores in pTRAM and fTRAM groups
were not significantly different from scores in the DIEP
group at both the first and second year post-reconstruction after adjusting for covariates,10 and scores improved
with time regardless of reconstruction approach. Similar
conclusions were observed in another multi-institution
study.9 Psychosocial and sexual well-being scores were also

not significantly different between MS fTRAM and DIEP
groups. In one study, patients receiving bilateral pTRAM
had higher SF-36 energy and well-being scores compared
with those receiving DIEP flaps (P < 0.05 and P = 0.06,
respectively).25 In another study, there were minimal differences in the SF-36 mental health composite score
between MS fTRAM and DIEP flaps at long-term followup.14 Although obese and non-obese patients had similar
preoperative scores, the SF-36 mental health composite
score improved in non-obese patients and worsened in
obese patients (P = 0.02).
Two studies measured satisfaction through a 7-item
questionnaire developed for the Michigan Breast
Reconstruction Outcome Study ,31,32 and two studies measured satisfaction using the BREAST-Q.9,10 Momoh et al.
demonstrated that recipients of DIEP flap reconstruction had significantly higher general satisfaction than
recipients of pTRAM flap reconstruction (P = 0.04).32 This
likelihood was even more pronounced in the bilateral
DIEP group compared with the bilateral pTRAM group
(P = 0.0095). In contrast, another study found that there were
no significant differences in general satisfaction between
pTRAM and DIEP groups.31 Both studies suggest similar
aesthetic satisfaction rates across different approaches to
reconstruction. Macadam et al. demonstrated that there
was significantly higher satisfaction with long-term outcome
in the DIEP group compared with the pTRAM group (P
= 0.015) after controlling for patient characteristics.9 This
finding did not reach significance when comparing fTRAM
or MS fTRAM with DIEP flaps, and the difference in satisfaction with breasts did not vary between pTRAM, fTRAM,
and DIEP groups after 1 and 2 years.9,10
Physical outcomes were assessed by the BREAST-Q
and SF-36. In one study, DIEP flap patients experienced
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Table 1. Summary of Included Studies
Year of
Publication
2002

Author

Country

2006

Nahabedian
et al.
Nahabedian
et al.
Bajaj et al.

United States

2006

Garvey et al.

United States

2007

Chen et al.

United States

2007
2010

Schaverien
et al.
Chun et al.

United
Kingdom
United States

2010

Nelson et al.

United States

2012

Momoh et al. United States

2013

Fischer et al.

United States

2014

BenditteKlepetko
et al.
Weichman
et al.

Netherlands

United States Prospective
and Canada
cohort

2015

Yang et al.

China

2016

Knox et al.

2016

Macadam
et al.

2018

ErdmannUnited States Prospective
Sager et al.
and Canada
cohort

2018

Xu et al.

China

2019

Nelson et al.

United States

2005

2015

United States

Study
Design

United States

Retrospective
cohort
Retrospective
cohort
Retrospective
cohort
Retrospective
cohort
Retrospective
cohort
Retrospective
cohort
Retrospective
cohort
Retrospective
cohort
Retrospective
cohort
Retrospective
cohort
Retrospective
cohort

Intervention Groups Compared
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Free TRAM (n = 118)
DIEP (n = 17)
Muscle-sparing free TRAM (n = 89)
DIEP (n = 88)
Muscle-sparing free TRAM (n = 124)
DIEP (n = 35)
Pedicled TRAM (n = 94)
DIEP (n = 96)
Free TRAM (n = 114)
DIEP (n = 29)
Free TRAM (n = 30)
DIEP (n = 30)
Pedicled TRAM (n = 105)
DIEP (n = 58)
Muscle-sparing free TRAM (n = 91)
DIEP (n = 53)
Pedicled TRAM (n = 179)
DIEP (n = 167)
Muscle-sparing free TRAM (n = 300)
DIEP (n = 105)
Free TRAM (n = 22)
DIEP (n = 18)

Prospective
cohort

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Pedicled TRAM (n = 83)
Free TRAM (n = 91)
DIEP (n = 296)
Pedicled TRAM (n = 44)
DIEP (n = 62)
Pedicled TRAM (n = 377)
DIEP (n = 130)
Pedicled TRAM (n = 683)
Free TRAM (MS-0) (n = 144)
Muscle-sparing free TRAM (n = 293)
DIEP (n = 670)
Pedicled TRAM (n = 89)
Free TRAM (n = 115)
DIEP (n = 445)
Pedicled TRAM (n = 39)
DIEP (n = 9)

Prospective
cohort

• Muscle-sparing free TRAM (n = 35)
• DIEP (n = 13)

Crosssectional
Canada
Retrospective
cohort
United States Retrospective
and Canada
cohort

significantly higher abdominal physical well-being compared with pTRAM flap patients after controlling for
cofounders (P < 0.001).9 Differences did not reach significance when comparing the DIEP flap to fTRAM and MS
fTRAM flaps. Similarly, no differences in abdominal wellbeing scores between MS fTRAM flaps and DIEP flaps were
noted in another study.14 The Mastectomy Reconstruction
Outcomes Consortium study showed higher abdomenspecific scores for DIEP compared with both pTRAM
and fTRAM flaps one year postoperatively (P = 0.078 and
P = 0.051, respectively) and significantly higher scores
two years postoperatively (P = 0.006 and P = 0.037) after
controlling for laterality, although in all groups unadjusted postoperative scores were lower than preoperative scores.10 The Mastectomy Reconstruction Outcomes
Consortium study demonstrated that unadjusted physical
chest well-being decreased from preoperative to 1 week
postoperatively in pTRAM, fTRAM, and DIEP groups, and
did not return to baseline levels at 3 months (P < 0.001).12
Multivariable analysis showed there was no significant
difference in physical well-being of chest scores between
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Patientreported
Complications Outcomes

Comments

X
X
X
X

Unilateral
flaps

X
X

X

X

X

Unilateral
flaps
Bilateral flaps

X
X

X

X

Obese
patients

X
X
X
X
X

X

X
X
X

X

Immediate,
unilateral
flaps

groups at 1 year postoperatively.10 Interestingly, however,
the pTRAM group reported significantly lower scores
at 2 years postoperatively compared to the DIEP group
(P = 0.04).
In one study, the SF-36 physical health composite score
significantly improved over time for both unilateral and
bilateral MS fTRAM and DIEP flaps (P < 0.05), although
no significant differences were noted during a direct comparison of flap type or laterality.14 Obesity lead to a significant worsening in the physical health composite score
over time (P = 0.003), while scores improved in non-obese
patients. In another study, no significant differences were
found between fTRAM and DIEP groups for scores on
the SF-36 physical functioning or physical role limitations
scales.11 Patients also reported that they rarely suffered
from postoperative abdominal pain for a mean duration
of 1–3 months.

DISCUSSION

This review evaluates abdominally based autologous
breast reconstruction techniques and provides updated
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Table 2. Pooled Complication Rates for pTRAM versus DIEP Flaps
pTRAM
Outcomes
Total or partial flap loss
Low-volume hospitals only
Mastectomy skin flap necrosis
Low-volume hospitals only
Fat necrosis (breast)
Low-volume hospitals only
Infection (breast)
Low-volume hospitals only
Hematoma/seroma (breast)
Low-volume hospitals only
Wound healing complications (breast)
Low-volume hospitals only
Abdominal bulge/hernia
Low-volume hospitals only
Wound healing complications (donor-site)
Low-volume hospitals only

DIEP

Studies,
N

No.
Events

No.
Patients

No.
Events

No.
Patients

Effect
Size

95%
CI

I2

6
4
3
2
6
4
5
4
5
4
4
3
5
3
3
2

90
22
80
69
342
147
184
78
96
70
97
91
174
55
129
120

1562
774
680
483
1667
774
1457
774
1468
785
774
577
1100
312
576
471

76
17
56
34
210
76
93
51
105
49
29
23
74
15
106
94

1233
505
409
192
1291
505
1175
505
1137
467
505
288
1000
272
284
226

1.03
1.15
0.36
0.86
1.43
1.63
1.63
1.39
0.76
0.84
1.49
1.64
2.82
3.08
0.59
0.68

−0.81 to 2.88
−1.08 to 3.39
−1.39 to 2.11
−2.30 to 4.02
−0.33 to 3.18
−0.53 to 3.80
−0.36 to 3.62
−0.87 to 3.65
−1.21 to 2.73
−1.39 to 3.07
−0.78 to 3.77
−1.03 to 4.31
0.83 to 4.80
0.46 to 5.70
−1.86 to 3.04
−2.30 to 3.66

36.62%
60.21%
0
0
90.50%
93.00%
86.59%
77.24%
30.37%
0
80.18%
83.62%
85.70%
48.08%
0
0

Table 3. Pooled Complication Rates for fTRAM versus DIEP Flaps
DIEP
Outcomes
Total or partial flap loss
Without obese patients
Muscle-sparing only

fTRAM

Studies,
N

No.
Events

No.
Patients

No.
Events

No.
Patients

Effect
Size

95%
CI

I2

8
7
4

73
68
65

1083
978
899

50
45
21

1401
1101
632

2.67
2.64
1.93

1.00 to 4.34
0.83 to 4.45
0.26 to 3.61

87.62%
88.57%
87.57%

Studies,
N
4
3
7
6
4
5
4
2
5
4
2
3
2
9
8
5

No.
Events
154
28
133
125
67
63
51
42
55
48
25
132
6
94
76
56

Effect
Size
0.96
1.03
0.80
0.89
0.83
2.60
2.93
2.10
0.80
0.85
0.43
0.93
0.96
2.87
2.35
2.55

95%
CI
−1.31 to 3.28
−1.71 to 3.77
−0.83 to 2.44
−0.88 to 2.66
−1.32 to 2.98
0.54 to 4.65
0.61 to 5.26
−1.04 to 5.23
−1.20 to 2.80
−1.40 to 3.10
−2.59 to 3.46
−1.74 to 3.59
−2.49 to 4.40
1.73 to 4.00
1.49 to 3.21
1.42 to 3.67

I2
0
0
0
0
0
71.51%
78.60%
70.20%
15.91%
36.80%
0
0
0
70.48%
41.44%
62.83%

fTRAM
Outcomes
Mastectomy skin flap necrosis
Without obese patients
Fat necrosis (breast)
Without obese patients
Muscle-sparing only
Infection (breast)
Without obese patients
Muscle-sparing only
Hematoma/seroma (breast)
Without obese patients
Muscle-sparing only
Wound healing complications, any (breast)
Without obese patients
Abdominal bulge/hernia
Without obese patients
Muscle-sparing only

flap selection criteria based on complications and patientreported outcomes. Consistent with previous reports in
the literature, we found a trend toward greater risk of
abdominal bulge/hernia following pTRAM compared
with DIEP flaps, reinforcing the notion that losing muscle
makes abdominal fascia prone to weakness.4,5 Vascular
complications, including flap loss and fat necrosis, also
trend towards greater likelihood following pTRAM, suggesting that tunneling a pedicled flap up to the chest compromises blood flow via kinking or compression of the
superior epigastric vessels, or that the pedicle blood supply
provides decreased perfusion.7,28,33 In contrast, DIEP flaps
benefit from the enhanced blood supply of the inferior
epigastric vessels or the flow dynamics from the internal
mammary or thoracodorsal system. These relative risks are
increased in low-volume hospitals, perhaps because lowvolume hospitals see patients with fewer comorbidities, for

No.
Patients
604
304
1430
1130
684
1041
741
560
1041
741
560
582
282
1253
953
612

DIEP
No.
Events
58
8
143
133
126
47
44
45
72
68
41
52
2
40
39
36

No.
Patients
235
130
1065
960
899
905
800
364
905
800
364
217
112
1030
925
855

whom microsurgery is preferred.4,5 Another possibility is
that because DIEP flap reconstructions have an increased
mean surgical time and steeper learning curve,22 patients
undergoing this procedure benefit from more careful
intraoperative technique and postoperative monitoring.
Albornoz et al. found that in higher-volume hospitals,
where surgical technique benefits from greater experience,34 patients undergoing microvascular reconstruction were also less likely to experience complications than
those undergoing autologous reconstructions in general.18
Further studies examining the association between hospital volume and complication rates following abdominallybased breast reconstruction, and differentiating between
pTRAM, fTRAM, and DIEP flaps, are necessary to create
flap-specific guidelines for improving safety.
There is a significantly greater risk of abdominal
bulge/hernia following fTRAM compared to DIEP and
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Fig. 2. Higher relative risk of abdominal bulge and hernia shown for pTRAM and fTRAM flaps compared
with that for DIEP flaps on meta-analysis, particularly for obese patients. The comparisons shown are (a)
pTRAM vs DIEP, (b) fTRAM vs DIEP, (c) fTRAM vs DIEP subgroup analysis excluding 1 study using obese
patients, and (d) MS fTRAM vs DIEP subgroup analysis. The horizontal lines represent the 95% confidence intervals for each study.
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Table 4. Summary of Patient-Reported Outcomes Findings
Direction of Finding

Outcome
Psychosocial
outcomes

Satisfaction

Study
Chun et al., 2010

+

Macadam et al.,
2016
Erdmann-Sager
et al., 2018
Nelson et al., 2019
Momoh et al., 2012

=

=

=

=

Yang et al., 2015

Physical
well-being

Macadam et al.,
2016
Erdmann-Sager
et al., 2018
Schaverien et al.,
2007
Weichman et al.,
2015
Macadam et al.,
2016
Erdmann-Sager
et al., 2018
Nelson et al., 2019

Pain

pTRAM versus DIEP

fTRAM
versus
DIEP

Statistical
Adjustment
No

=

Yes
Yes

=

General satisfaction: Aesthetic satisfaction: =
=
Satisfaction breasts: =
Satisfaction outcome: =

MS
fTRAM
versus
DIEP

No
No
No

=

=

Yes

Measure
SF-36 energy/fatigue
SF-36 emotional well-being
BREAST-Q psychosocial well-being
BREAST-Q sexual well-being
BREAST-Q psychosocial well-being
BREAST-Q sexual well-being
SF-36 mental health composite
MBROS general satisfaction
MBROS aesthetic satisfaction
MBROS general satisfaction
MBROS aesthetic satisfaction
BREAST-Q satisfaction breasts
BREAST-Q satisfaction outcome
BREAST-Q satisfaction breasts

=

Yes

=

No

=

=

Yes

SF-36 physical functioning
SF-36 physical role limitations
BREAST-Q PWB chest

-

=

Yes

BREAST-Q PWB abdomen

Yes

BREAST-Q PWB chest
BREAST-Q PWB abdomen

No

BREAST-Q PWB abdomen
SF-36 physical health composite
SF-36 pain

=

PWB chest (one year): = PWB chest: =
PWB chest (two year): - PWB abdomen: PWB abdomen: -

Schaverien et al.,
2007

=

=

No

Bold entries indicate the studies finding statistically significant differences in patient-reported outcome scores between flaps (i.e. the direction of finding is either
+ or -).
+ score for first reconstruction technique higher than score for second reconstruction technique.
- score for second reconstruction technique higher than score for first reconstruction technique.
= scores equivalent for both reconstruction techniques.
SF-36, short-form 36; MBROS, Michigan Breast Reconstruction Outcome Study.

MS fTRAM flaps. Notably, relative to non-obese patients,
obese patients experience a higher risk of abdominal
bulge/hernia with fTRAM compared with DIEP flaps; so
DIEP flaps should be performed in this population if possible. Obesity may increase the risk of abdominal bulge/
hernia following fTRAM flaps due to increased tension
being placed on the weakened abdominal fascia.15 These
healing problems may be mitigated following DIEP flaps,
which leave less of an abdominal wall defect.35 Our findings also indicate that muscle conservation increases the
relative risk of flap loss. Therefore, DIEPs pose a greater
risk of flap loss compared with MS fTRAM flaps, while
fTRAM flaps pose the least risk. As fewer perforating vessels are included with DIEP compared with free TRAM
flaps, there is potential for less robust vascular supply.6,7
Studies reported significant differences in patientreported outcomes following TRAM and DIEP flap reconstructions. Patients undergoing pTRAM flaps tended
to report lower general satisfaction; lower physical wellbeing, as measured by the BREAST-Q; and higher energy
and emotional well-being, as measured by the SF-36.
However, there were no differences in psychosocial and
sexual well-being, or breast and aesthetic satisfaction. This
indicates that although patients receiving pTRAM flap
reconstruction have higher rates of abdominal morbidity

and are less satisfied with their physical recovery process,12
they are still ultimately satisfied with their aesthetic outcome. They may even be more energetic and positive
immediately postoperatively, following shorter operating
times and lengths of stay.16,25,36 Thus, although free abdominally based flaps have a more favorable complication profile, pTRAM flaps may still be useful for certain patients,
particularly when microsurgery is not an option secondary
to surgeon expertise, comfort level or patient preference
based on risk-weighted decisions. Patient-reported outcomes following fTRAM, MS fTRAM, and DIEP flaps were
similar, with the exception of higher BREAST-Q abdominal physical well-being scores in DIEP flaps compared with
fTRAM flaps. This again suggests that while surgeons are
highly concerned with donor-site morbidity, patients have
a more holistic perspective toward well-being.
On the basis of these findings, we outline several recommendations for preoperative flap selection (Fig. 3). To
decrease risk of abdominal bulge/hernia, muscle-sparing
flaps (particularly DIEP, but also MS fTRAM flaps) should
be considered before fTRAM among women who are
appropriate microsurgical candidates, particularly those
who are obese.13 Based on a previous meta-analysis, raising muscle-sparing flaps in obese patients may also have
the additional benefit of lowering risk for flap loss and fat
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Fig. 3. Higher relative risk of total and partial flap loss shown for DIEP flaps compared with fTRAM flaps on meta-analysis. The comparisons
shown are (a) DIEP vs fTRAM and (b) DIEP vs MS fTRAM subgroup analysis.

necrosis.16 Our findings with regard to DIEP flaps in obese
patients contrast with conventional recommendations,
suggesting that TRAM flaps should be raised for obese
patients.27,29 Additionally, given higher rates of abdominal
morbidity, the use of synthetic mesh for fascial closure
may have particular utility in obese patients and should be
investigated in future work.37,38 To prevent vascular complications such as flap loss, planned DIEP and MS fTRAM
flap reconstructions should be converted to fTRAM flaps
if surgeons are unable to identify perforators greater
than 1.5 mm in the same intermuscular septum.11,23,26,27,29
If microsurgical breast reconstruction is unavailable or if
the patient is too unstable to undergo a prolonged operation, pTRAM flaps should be performed despite the trend
toward an increased risk of flap-related and abdominal
morbidity. Finally, while this review does not explore nonclinical patient characteristics such as preoperative activity
level, it is important to remember that patient goals are
vital to the flap selection process. For example, a woman
who desires less fatigue and emotional toll during recovery may opt to pursue pTRAM flap reconstruction despite
the increased risk of abdominal morbidity.16,25,36
Because the current literature is limited by a lack of randomized controlled trials and because patients undergoing different flap reconstruction techniques are often not
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equivalent surgical candidates, it is particularly important
for cohort studies to report patient demographic, clinical,
and treatment characteristics as well as to use analysis methods that control for these characteristics. Yet more than
half of the included studies were characterized by a moderate or severe bias due to confounding (see Supplemental
Digital Content 1, http://links.lww.com/PRSGO/B491).
Our statistical analysis attempted to control for obesity and
hospital procedure volume status, and our findings regarding complication rates are consistent with those reported
by consortium and national database studies,10,39,40 which
are less likely to be biased by single-surgeon and hospital
factors. Due to a lack of extractable data, we were unable
to control for other preoperative risk factors. More highquality, prospective cohort studies are therefore needed to
demonstrate how additional patient characteristics impact
complication rates and patient well-being.
The lack of standardization in flap harvest techniques
creates another potential source of bias. Due to surgeonspecific variations in technique, MS fTRAM flaps at one
institution may be coded as DIEP flaps at another institution, thereby confounding the results. This review
demonstrates that increased muscle harvest is associated
with increased relative risk of abdominal bulge/hernia
and other complications. However, several studies do not

He et al. • Complications and PROs after TRAM and DIEP Flaps

Fig. 4. Evidence-based decision-making algorithm for abdominally based breast reconstruction options (ie, pTRAM, fTRAM, MS fTRAM,
and DIEP flaps).

report which degree of muscle-sparing surgery they perform during MS fTRAM flap reconstruction.9,13,14,23,26,27
As muscle-sparing flap harvest techniques become more
popular and new variations are developed,41 for the sake
of accurate outcomes reporting and patient counseling,
it is increasingly important for surgeons to adhere to a
uniform classification system of muscle wall preservation.
DellaCroce et al. has expanded on the traditional classification system by offering a specific definition for the
point at which muscle transection in the DIEP flap harvest
equates to a muscle-sparing fTRAM flap.
The use of the abdominal wall for autologous breast
reconstruction is an optimized procedure for both aesthetic and functional outcomes. Our findings demonstrate that complications and patient-reported outcomes
following abdominally based breast reconstruction techniques depend on flap type as well as patient- (ie, obesity) and hospital-level factors (ie, procedure volume).
When possible, DIEP and MS fTRAM reconstructions
should be performed for obese patients to decrease risk
of abdominal bulge/hernia. Although pTRAM flaps are
associated with a greater risk of complications, particularly in low-volume hospitals, they may still be an appropriate option when microsurgery is not available. When
selecting the appropriate abdominally based flap type for
autologous breast reconstruction, surgeon expertise must
be balanced with patient preferences, and risks of flapand donor-site morbidity must be weighed with patient
wishes and comorbidities. This systematic review is a useful guide that will inform both patient and provider in the
shared decision-making process. Maintaining transparency regarding potential safety and satisfaction outcomes
will allow these discussions to take place in an open and
honest manner.
Justin M. Sacks, MD, MBA
Division of Plastic and Reconstructive Surgery
Washington University School of Medicine in St. Louis
St. Louis, MO 63110
E-mail: jmsacks@wustl.edu
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